Spravato, also known as esketamine, is a cutting-edge treatment for individuals struggling with treatment-resistant depression and other mental health conditions. As a derivative of ketamine, esketamine has been shown to provide rapid relief from depressive symptoms, particularly for those who haven’t responded to traditional antidepressants. At We Conquer Together, we are proud to offer this FDA-approved therapy to our patients in Orange County, giving them access to an innovative and effective treatment option that can make a real difference in their lives.
Spravato is the brand name for esketamine, a prescription nasal spray developed to treat major depressive disorder, particularly in individuals who have not found relief through traditional antidepressants. Esketamine is a form of ketamine, a medication originally used for anesthesia but later discovered to have rapid-acting antidepressant properties. Unlike typical antidepressants that can take weeks to show effects, Spravato works quickly, often alleviating symptoms of depression within hours or days.
Approved by the FDA in 2019, Spravato is administered under the supervision of a healthcare provider in a controlled setting, ensuring that patients are monitored for any side effects. It is specifically designed for adults with treatment-resistant depression and is often used in conjunction with an oral antidepressant to boost its effectiveness. By targeting glutamate receptors in the brain, Spravato helps restore neural pathways that may have been damaged by chronic depression, offering a new avenue of hope for those who have exhausted other treatment options.
Spravato (esketamine) is primarily known for its effectiveness in treating major depressive disorder (MDD), particularly in individuals who have not responded to traditional treatment methods. However, its therapeutic potential extends beyond just treatment-resistant depression. By targeting the brain’s glutamate system, Spravato can provide relief for a variety of mental health conditions that have been difficult to manage with standard treatments.
Conditions Spravato is effective at treating include:
Spravato’s versatility in treating a range of mental health conditions highlights its importance as an advanced treatment option for patients who have struggled to find relief through traditional methods. Although its primary use is for treatment-resistant depression, ongoing research continues to explore its broader applications, potentially expanding its role in mental health care.
Spravato has shown significant effectiveness in treating individuals with treatment-resistant depression, offering a new solution for those who have not benefited from traditional antidepressants. Clinical trials and real-world use have demonstrated that Spravato can rapidly reduce symptoms of depression, with some patients experiencing improvements within hours of their first dose. This rapid response is particularly critical for patients with severe depression, including those with suicidal ideation, as it can provide relief when other therapies have failed to deliver timely results.
Studies have found that patients receiving Spravato, in combination with an oral antidepressant, are more likely to experience a reduction in depression symptoms compared to those who receive a placebo. Many patients report long-lasting improvements in mood and overall functioning with continued treatment. However, as with any treatment, individual results may vary. Some patients may experience side effects, such as dizziness or dissociation, but these are generally well-managed with the oversight of medical professionals during treatment sessions. Overall, Spravato has proven to be an effective and valuable option for individuals facing the challenges of treatment-resistant depression.
Spravato therapy offers a revolutionary approach to treating depression, especially for individuals who have not responded to traditional antidepressants. With its rapid action and unique mechanism, it provides significant relief to those suffering from treatment-resistant depression. Below are five key benefits of Spravato therapy:
One of the most notable benefits of Spravato is its ability to provide rapid relief from depressive symptoms. Unlike conventional antidepressants, which can take weeks to become effective, Spravato may reduce symptoms within hours or days. This fast-acting treatment is crucial for individuals experiencing severe depression or suicidal thoughts, offering them much-needed relief sooner.
Spravato is specifically designed for individuals who have not found success with other antidepressant medications. If a patient has tried two or more antidepressants without significant improvement, they may be considered a candidate for Spravato. This makes it a valuable option for those who have exhausted traditional treatments and are in need of a new, effective therapy.
Spravato is administered as a nasal spray, making it a convenient and non-invasive treatment option. Patients do not need to undergo IV infusions or take oral medications daily. Instead, they receive the nasal spray under medical supervision in a comfortable setting, minimizing discomfort while ensuring the treatment is administered correctly.
Unlike most antidepressants, which target serotonin, dopamine, or norepinephrine, Spravato works by affecting the glutamate system in the brain. This pathway plays a crucial role in mood regulation and cognitive function. By restoring this system, Spravato helps create new neural connections, promoting long-term improvements in mood and mental clarity.
Spravato therapy is administered in a controlled environment by trained healthcare providers. Each session is personalized based on the patient’s specific needs and mental health condition. This level of supervision ensures safety throughout the treatment process, allowing for real-time adjustments and monitoring of potential side effects.
At We Conquer Together, we believe that every individual deserves the opportunity to reclaim their mental health and live a life free from the burden of severe depression. With advanced treatments like Spravato (esketamine) therapy, we offer hope to those who have not found relief through traditional methods. Our team of dedicated mental health professionals provides compassionate care in a safe, supportive environment, helping you power through even the toughest mental health challenges.
If you or a loved one are struggling with treatment-resistant depression or other mental health conditions, don’t wait to seek the help you deserve. Reach out to We Conquer Together today to learn more about how Spravato therapy and our other comprehensive treatment options can make a difference in your life. Let us support you on your journey to wellness and recovery.
We Conquer Together
We firmly believe that the internet should be available and accessible to anyone, and are committed to providing a website that is accessible to the widest possible audience, regardless of circumstance and ability.
To fulfill this, we aim to adhere as strictly as possible to the World Wide Web Consortium’s (W3C) Web Content Accessibility Guidelines 2.1 (WCAG 2.1) at the AA level. These guidelines explain how to make web content accessible to people with a wide array of disabilities. Complying with those guidelines helps us ensure that the website is accessible to all people: blind people, people with motor impairments, visual impairment, cognitive disabilities, and more.
This website utilizes various technologies that are meant to make it as accessible as possible at all times. We utilize an accessibility interface that allows persons with specific disabilities to adjust the website’s UI (user interface) and design it to their personal needs.
Additionally, the website utilizes an AI-based application that runs in the background and optimizes its accessibility level constantly. This application remediates the website’s HTML, adapts Its functionality and behavior for screen-readers used by the blind users, and for keyboard functions used by individuals with motor impairments.
If you’ve found a malfunction or have ideas for improvement, we’ll be happy to hear from you. You can reach out to the website’s operators by using the following email
Our website implements the ARIA attributes (Accessible Rich Internet Applications) technique, alongside various different behavioral changes, to ensure blind users visiting with screen-readers are able to read, comprehend, and enjoy the website’s functions. As soon as a user with a screen-reader enters your site, they immediately receive a prompt to enter the Screen-Reader Profile so they can browse and operate your site effectively. Here’s how our website covers some of the most important screen-reader requirements, alongside console screenshots of code examples:
Screen-reader optimization: we run a background process that learns the website’s components from top to bottom, to ensure ongoing compliance even when updating the website. In this process, we provide screen-readers with meaningful data using the ARIA set of attributes. For example, we provide accurate form labels; descriptions for actionable icons (social media icons, search icons, cart icons, etc.); validation guidance for form inputs; element roles such as buttons, menus, modal dialogues (popups), and others. Additionally, the background process scans all the website’s images and provides an accurate and meaningful image-object-recognition-based description as an ALT (alternate text) tag for images that are not described. It will also extract texts that are embedded within the image, using an OCR (optical character recognition) technology. To turn on screen-reader adjustments at any time, users need only to press the Alt+1 keyboard combination. Screen-reader users also get automatic announcements to turn the Screen-reader mode on as soon as they enter the website.
These adjustments are compatible with all popular screen readers, including JAWS and NVDA.
Keyboard navigation optimization: The background process also adjusts the website’s HTML, and adds various behaviors using JavaScript code to make the website operable by the keyboard. This includes the ability to navigate the website using the Tab and Shift+Tab keys, operate dropdowns with the arrow keys, close them with Esc, trigger buttons and links using the Enter key, navigate between radio and checkbox elements using the arrow keys, and fill them in with the Spacebar or Enter key.Additionally, keyboard users will find quick-navigation and content-skip menus, available at any time by clicking Alt+1, or as the first elements of the site while navigating with the keyboard. The background process also handles triggered popups by moving the keyboard focus towards them as soon as they appear, and not allow the focus drift outside it.
Users can also use shortcuts such as “M” (menus), “H” (headings), “F” (forms), “B” (buttons), and “G” (graphics) to jump to specific elements.
We aim to support the widest array of browsers and assistive technologies as possible, so our users can choose the best fitting tools for them, with as few limitations as possible. Therefore, we have worked very hard to be able to support all major systems that comprise over 95% of the user market share including Google Chrome, Mozilla Firefox, Apple Safari, Opera and Microsoft Edge, JAWS and NVDA (screen readers).
Despite our very best efforts to allow anybody to adjust the website to their needs. There may still be pages or sections that are not fully accessible, are in the process of becoming accessible, or are lacking an adequate technological solution to make them accessible. Still, we are continually improving our accessibility, adding, updating and improving its options and features, and developing and adopting new technologies. All this is meant to reach the optimal level of accessibility, following technological advancements. For any assistance, please reach out to